AI assistant
Sending…
AMGEN INC — Director's Dealing 2012
Aug 8, 2012
29819_dirs_2012-08-08_ff1e44e9-5139-46be-89db-4e7b9cb67962.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-08-06
Reporting Person: REASON J PAUL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-08-06 | Common Stock | M | 5000 | $62.55 | Acquired | 24408 | Direct |
| 2012-08-06 | Common Stock | M | 5000 | $42.13 | Acquired | 29408 | Direct |
| 2012-08-06 | Common Stock | M | 5000 | $50.44 | Acquired | 34408 | Direct |
| 2012-08-06 | Common Stock | M | 5000 | $58.43 | Acquired | 39408 | Direct |
| 2012-08-06 | Common Stock | M | 5000 | $54.69 | Acquired | 44408 | Direct |
| 2012-08-06 | Common Stock | F | 3805 | $82.21 | Disposed | 40603 | Direct |
| 2012-08-06 | Common Stock | F | 2563 | $82.21 | Disposed | 38040 | Direct |
| 2012-08-06 | Common Stock | F | 3068 | $82.21 | Disposed | 34972 | Direct |
| 2012-08-06 | Common Stock | F | 3554 | $82.21 | Disposed | 31418 | Direct |
| 2012-08-06 | Common Stock | F | 3327 | $82.21 | Disposed | 28091 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-08-06 | Nqso (Right to Buy) | $62.55 | M | 5000 | Disposed | 2014-04-26 | Common Stock (5000) | Direct |
| 2012-08-06 | Nqso (Right to Buy) | $42.13 | M | 5000 | Disposed | 2015-04-29 | Common Stock (5000) | Direct |
| 2012-08-06 | Nqso (Right to Buy) | $50.44 | M | 5000 | Disposed | 2016-04-28 | Common Stock (5000) | Direct |
| 2012-08-06 | Nqso (Right to Buy) | $58.43 | M | 5000 | Disposed | 2020-04-26 | Common Stock (5000) | Direct |
| 2012-08-06 | Nqso (Right to Buy) | $54.69 | M | 5000 | Disposed | 2021-04-25 | Common Stock (5000) | Direct |
Footnotes
F1: These shares include 124 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's unvested, and vested but deferred, Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.
More from AMGEN INC
Audit Report / Information
2026
Jun 11
Audit Report / Information
2026
Jun 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Board/Management Information
2026
May 19
Interim / Quarterly Report
2026
May 1
Earnings Release
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Board/Management Information
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15